Syndax Pharmaceuticals

Every April, we honor National Donate Life Month, an opportunity to celebrate and remember those who have given patients in need a chance at living a full life. This #LivingDonorDay, we share our heartfelt appreciation to all donors for giving patients the gift of life. #WeFlyHigherTogether #DonateLifeMonth

At Syndax, we are committed to reimagining cancer care. Courtney, Senior People Team Associate, shares why she joined Syndax and how we all play a role in making a difference for patients. #WeFlyHigherTogether

Two days away! We’re thrilled to be joining The EBMT’s #EBMT25, where we will be presenting six Syndax and Incyte co-sponsored posters on the axatilimab-csfr program. Learn more: https://lnkd.in/eZ59mf8E

The Leukemia & Lymphoma Society's Light the Night is more than just an event—it's a powerful reminder of our mission at Syndax. Hear from our team members about their personal connections to this cause and why they're passionate about finding a cure. #LightTheNight #Syndaxers

#MarkYourCalendars: Join us for a fireside chat during the Barclays 27th Annual Global Healthcare Conference tomorrow, March 13. At 8:30 a.m. ET, members of Syndax’s management team will take the stage and highlight how we are delivering on our mission for patients. Access the webcast below: https://lnkd.in/gZsWjxqj A live replay will be available after the call concludes.

Last month, our workforce came together during the #RevolutionTour2025 all-company celebration. Our theme, “Revolution,” centered around the idea of what it means to develop and deliver revolutionary science in service of patients with urgent unmet need. In addition to hearing from Syndax leadership and our cross-functional colleagues during our meeting, we had the privilege of welcoming #AML survivor Sarah, who shared her patient journey with grit, gratitude and grace. Later, The Leukemia & Lymphoma Society’s Senior Clinical Trial Nurse Navigator, Ashley, took the stage to highlight the importance of patient advocacy. We concluded the second day of our meeting writing notes and packing Jessie’s JoyJars® for 860 courageous kids fighting cancer in partnership with the Jessie Rees Foundation (TeamNEGU: Never Ever Give Up!). At Syndax, our passion for patients underpins all that we do, and we would like to extend our heartfelt gratitude to our presenters, colleagues and special guests who helped reinforce our continued commitment to reimagining cancer care.

Happy International Women’s Day! #IWD2025 serves as an opportunity to pay tribute to the social, economic, cultural and political achievements of women and advocate for equal rights and opportunities for all. Today and every day, we’re proud to honor the many contributions of our Syndaxers and their commitment to making a difference. #AccelerateAction #WeFlyHigherTogether

At Syndax, learning isn’t just encouraged—it’s one of our core values.    Hear from Dr. Peter Ordentlich, our CSO and founder, about what 'Always Learning' means to him.   #CoreValues #WeFlyHigherTogether

#HappeningSoon: This afternoon, members of Syndax’s management team will be participating in a fireside chat during the TD Cowen 45th Annual Health Care Conference. Tune in at 3:10 p.m. ET to learn how we are reimagining cancer care: https://lnkd.in/gvta6RzU A live replay will be available for a limited time.

#NewsAlert: Today, we reported our fourth quarter and full year 2024 financial results and provided a business update. We are off to a strong start with the U.S. launch of Revuforj® (revumenib) and are very encouraged by the early patient demand and breadth of prescribing, as well as the favorable coverage from payers. With two first-in-class medicines on the market that address major unmet needs and a robust development strategy underway, Syndax is well-positioned for long-term success. Learn more by reading our full release and joining us on our conference call today at 8:00 a.m. ET: https://lnkd.in/gXEkPJqB A live replay will be available for a limited time.